Artwork

内容由Learn Advocate Connect Neuroendocrine Tumor Society提供。所有播客内容(包括剧集、图形和播客描述)均由 Learn Advocate Connect Neuroendocrine Tumor Society 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Treatment for NETs with NET Expert Dr. Randy Hecht

1:07:39
 
分享
 

Manage episode 349899335 series 3426844
内容由Learn Advocate Connect Neuroendocrine Tumor Society提供。所有播客内容(包括剧集、图形和播客描述)均由 Learn Advocate Connect Neuroendocrine Tumor Society 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

What are the current treatment options for NETs? How do I know what treatments I should be on? In our fifth episode, NET expert and Medical Oncologist Dr. Randy Hecht of UCLA Health answers ten common questions about current NET treatment options (including lanreotide, octreotide, everolimus, and PRRT), as well as future treatment options. Listen now!

For more information, visit LACNETS.org.

  continue reading

42集单集

Artwork
icon分享
 
Manage episode 349899335 series 3426844
内容由Learn Advocate Connect Neuroendocrine Tumor Society提供。所有播客内容(包括剧集、图形和播客描述)均由 Learn Advocate Connect Neuroendocrine Tumor Society 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

What are the current treatment options for NETs? How do I know what treatments I should be on? In our fifth episode, NET expert and Medical Oncologist Dr. Randy Hecht of UCLA Health answers ten common questions about current NET treatment options (including lanreotide, octreotide, everolimus, and PRRT), as well as future treatment options. Listen now!

For more information, visit LACNETS.org.

  continue reading

42集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南